David P. Nau, PhD

Articles by David P. Nau, PhD

Medicare Advantage–Pharmacy Partnership Improves Influenza and Pneumococcal Vaccination Rates

ByRichard L. Sheer, BA,David P. Nau, PhD,Nicholas Dorich, PharmD,Jesse McCullough, PharmD,Annette D. Boyer, RPh,Matthew Pickering, PharmD,Patrick J. Campbell, PharmD, PhD,Margaret K. Pasquale, PhD

October 13th 2021

Patients whose pharmacy receives notification of their immunization gap have twice the odds of receiving immunizations compared with those whose pharmacy does not receive the notification.

Recommendations for Improving Adherence to Type 2 Diabetes Mellitus Therapy-Focus on Optimizing Oral and Non-Insulin Therapies

ByDavid P. Nau, PhD

April 20th 2012

Sex Disparity in the Management of Dyslipidemia Among Patients With Type 2 Diabetes Mellitus in a Managed Care Organization

ByDavid P. Nau, PhD,Usha Mallya, MS

February 1st 2005

David P. Nau, PhD

Articles by David P. Nau, PhD

Medicare Advantage–Pharmacy Partnership Improves Influenza and Pneumococcal Vaccination Rates

Recommendations for Improving Adherence to Type 2 Diabetes Mellitus Therapy-Focus on Optimizing Oral and Non-Insulin Therapies

Sex Disparity in the Management of Dyslipidemia Among Patients With Type 2 Diabetes Mellitus in a Managed Care Organization

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access